Unlock Exclusive Discounts & Flash Sales! Click Here to Join the Deals on Every Wednesday!

Epitope Mapping Analysis of Anti-Human LAG3 Rabbit Antibody Clone by Surface Plasmon Resonance (SPR) (CAT#: STEM-MB-0629-CJ)

Introduction

Lymphocyte activation gene 3 (LAG3) is a T cell inhibitory receptor that promotes tumor cell immune escape and is a potential target for cancer diagnostic and immunotherapeutic applications.<br /><br />The immunomodulatory protein, Lymphocyte activation gene 3 (LAG3) (CD223) was discovered over 30 years ago. As a novel member of the immunoglobulin (Ig) superfamily. LAG3 is a transmembrane protein with four extracellular Ig-like domains that show approximately 20% amino acid homology with CD4. Surface expression of the LAG3 receptor is induced on CD4+ and CD8+ T cells upon antigen stimulation, and functions as a negative regulator of T cell cytotoxicity. And the inhibitory function of LAG3 strongly correlates with the level of surface expression and subsequently, high LAG3, on tumor infiltrating lymphocytes, is associated with a poor prognosis. Preclinical and early clinical trials have indicated that active LAG3 promotes tumor cell immune escape. Inhibition of LAG3 restores T cell activity, and is synergistic with inhibition of PD-1, making it a prime target for immunotherapy.




Principle

SPR can be also used for thermodynamic analysis, epitope mapping, and to determine analyte concentration. The SPR-based binding method involves immobilization of a ligand on the surface of a sensor chip which has a monolayer of carboxymethylated dextran covalently attached to a gold surface. The ligand of interest is immobilized on the surface of the sensor chip using well-defined chemistry allowing solutions with different concentrations of an analyte to flow over it and to characterize its interactions to the immobilized ligand. The SPR signal originates from changes in the refractive index at the surface of the gold sensor chip. The increase in mass associated with a binding event causes a proportional increase in the refractive index, which is observed as a change in response. These changes are measured as changes in the resonance angle (δθ) of refracted light when the analyte, flowing in a microfluidic channel, binds to the immobilized ligand and increases in density at the sensor chip.

Applications

Oncology & Cancer; Immunology/Inflammation; Pharmacology

Procedure

The instrument capable of automated or manual surface preparation, fully automated injection of test samples in well, and output of SPR data as proprietary datafiles for evaluation with software.
1. Receptor Immobilisation (Surface Preparation): This stage is required to coat the biosensor surface with the target receptor (protein) to which the test compound (ligand) will bind. A variety of different immobilization / capture strategies are available, depending on the nature of the receptor. Usually, a control receptor (protein) to which the test compound won't bind, is also coated onto a reference surface to act as a 'blank'.
2. Ligand Binding and Dissociation: (Sample Injection and Wash-off Intervals) After establishing a stable baseline with buffer alone flowing over the sensor surface, sample is passed over the receptor surface for binding to occur. This period defines the binding association rate. After a defined interval, sample flow ceases and flow of buffer alone is resumed. This allows the bound ligand to wash off, defining the dissociation rate. The duration of the ligand binding and ligand dissociation intervals needs to be sufficient to measure binding kinetics but should be as short as practical to conserve reagents and increase sequential sample throughput.
3. Surface Regeneration (Bound Ligand Removal): Samples are passed over the sensor surface sequentially. For low-affinity ligands, dissociation can be complete (back to initial baseline level) within a few minutes, allowing the next sample to be injected onto a 'clean' sensor surface after a short delay. For high affinity ligands, complete dissociation back to baseline can take hours, but only a few minutes of dissociation rate data are required for analysis. To remove all bound ligand from the sensor surface before the next sample is injected, a 'regeneration' step can be used. This process applies a mild pH change, ionic strength change, or some other biophysical process to rapidly dissociate the ligand from the receptor surface without damaging or denaturing the receptor protein. After returning to baseline with standard buffer flow, the next sample can be injected.
4. Data Analysis: Automated data analysis is performed using proprietary evaluation software.
5. Data Output.

Materials

• Sample: Complex mixtures (such as: cell culture supernatants, cell extracts, purified interactants); Small molecules; Peptides; Proteins; Antibody; Nucleic acids; Lipids; Virus-like particles (VLPs); Hormones/Cytokines; Adeno-associated viruses (AAV)
• Equipment: Biacore™ Surface Plasmon Resonance (SPR)
• Running buffer; DMSO; Detergent
• (Optional) 96-well and 384-well reagent plates and foil

Notes

1. One of the samples to be tested must be a protein and both samples must be of high purity.
2. Minimum sample sizes available: proteins (50-100μg), small molecules (20μM/200μL), proteins and peptides need to be sent at low temperature.
3. If use DMSO, make sure all equipment (pipette tips, microplates, vials, filters, and so on) are compatible with organic solvents. Do not use polystyrene products with DMSO.